Summary
A Phase IIb, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the safety, tolerability and efficacy of Study Drug in adults with chronic hepatitis C virus infection.
Register to download
PRA Exceeds Tough Enrollment Goals
You may also be interested in:
page
Patient Perspective
Read More
page
Clinical Development
We work hand-in-hand with our sponsors to develop strategic, flexible approaches that leverage Clinical Informatics, state-of-the-art technologies,…
Read More
page
Symphony Health
Symphony Health - A PRA Health Sciences Company. Where remarkable people turn healthcare data into actionable strategy.
Read More
View all related content and resources for Patient Recruitment and Retention
Explore Insights